CLONAZEPAM (PORT. 344/98 – LISTA B1) 2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1256802300018 -
GGREM
528512040116206 -
Código de barras
7899547502251
O que a fonte publica
- Detentor do registro
- PRATI DONADUZZI & CIA LTDA
- Princípios ativos
- CLONAZEPAM
- Embalagem
- 2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML
- Tipo de produto
- Genérico
- Classe terapêutica
- N3A - ANTIEPILÉPTICOS
Nomes pelos quais este registro é encontrado
- CLONAZEPAM (PORT. 344/98 – LISTA B1) 2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML
- CLONAZEPAM (PORT. 344/98 – LISTA B1)
- CLONAZEPAM
Dados completos da fonte
{
"name": "CLONAZEPAM (PORT. 344/98 – LISTA B1) 2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML",
"holder": "PRATI DONADUZZI & CIA LTDA",
"stripe": null,
"barcodes": [
"7899547502251"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "528512040116206",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.856.593/0001-66",
"priceRegime": "Regulado",
"productName": "CLONAZEPAM (PORT. 344/98 – LISTA B1)",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "11.88",
"icms-12": "13.50",
"icms-17": "14.31",
"icms-18": "14.49",
"icms-19": "14.67",
"icms-20": "14.85",
"icms-21": "15.04",
"icms-22": "15.23",
"icms-23": "15.43",
"icms-17.5": "14.40",
"icms-19.5": "14.76",
"icms-20.5": "14.94",
"icms-22.5": "15.33",
"icms-12-alc": "13.34",
"icms-17-alc": "14.14",
"icms-18-alc": "14.31",
"icms-19-alc": "14.49",
"icms-20-alc": "14.67",
"icms-21-alc": "14.86",
"icms-22-alc": "15.05",
"icms-23-alc": "15.24",
"withoutTaxes": "11.74",
"icms-17.5-alc": "14.23",
"icms-19.5-alc": "14.58",
"icms-20.5-alc": "14.76",
"icms-22.5-alc": "15.15"
},
"pisCofinsList": "Positiva",
"substanceText": "CLONAZEPAM",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "16.38",
"icms-12": "18.61",
"icms-17": "19.72",
"icms-18": "19.97",
"icms-19": "20.22",
"icms-20": "20.47",
"icms-21": "20.73",
"icms-22": "20.99",
"icms-23": "21.27",
"icms-17.5": "19.85",
"icms-19.5": "20.35",
"icms-20.5": "20.59",
"icms-22.5": "21.13",
"icms-12-alc": "18.44",
"icms-17-alc": "19.55",
"icms-18-alc": "19.78",
"icms-19-alc": "20.03",
"icms-20-alc": "20.28",
"icms-21-alc": "20.54",
"icms-22-alc": "20.81",
"icms-23-alc": "21.07",
"withoutTaxes": "16.23",
"icms-17.5-alc": "19.67",
"icms-19.5-alc": "20.16",
"icms-20.5-alc": "20.40",
"icms-22.5-alc": "20.94"
},
"invalidBarcodes": [],
"activeSubstances": [
"CLONAZEPAM"
],
"therapeuticClass": "N3A - ANTIEPILÉPTICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1256802300018",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "N3A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:528512040116206"